Prophylaxis in orthopaedic implant surgery--should we use a glycopeptide?
Sanderson
P J
PJ
Microbiology Department, Wellhouse (NHS) Trust, Edgware Community Hospital, Middlesex, UK.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019643:Arthroplasty, Replacement / Q000009:adverse effects*; D006801:Humans; D016106:Methicillin Resistance; D011183:Postoperative Complications / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D013203:Staphylococcal Infections / Q000517:prevention & control*; D013211:Staphylococcus aureus / Q000187:drug effects; D013212:Staphylococcus epidermidis / Q000187:drug effects; D017334:Teicoplanin / Q000008:administration & dosage / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D017334:Teicoplanin